New Synthetic Molecules Direct Stem Cell Differentiation.
News Sep 09, 2008
A collaborative team of scientists from Durham University and the North East England Stem Cell Institute (NESCI) have developed two synthetic molecules which can be used to coax stem cells to ‘differentiate’ - that is, transform into other forms of tissue.
The new molecules, called EC23 and EC19, have been found in robust scientific tests to be far more stable than the naturally-occurring molecule currently used to induce stem cells to differentiate in the laboratory, known as All-trans-retinoic Acid (ATRA). Their use will thus improve the reliability of experiments.
The scientists, who tested the effectiveness of EC23 and EC19 on four types of stem cells, say it is also significant that each individual synthetic molecule has been found to be more effective at causing the cells to transform into specific types of tissue. For example, EC23 was found to be particularly effective at producing neurons (nerve cells) which can be used in laboratory testing for drugs for brain disorders such as Alzheimer’s Disease and Parkinson’s Disease.
In contrast, EC19 was found to be particularly effective at producing epithelial cells – the cells that line the inner and outer surfaces of the body.
The team consisted of synthetic chemists, Dr Andrew Whiting and Professor Todd Marder and stem cell biologist, Dr Stefan Przyborski and their research groups at Durham University, who are all members of the North East England Stem Cell Institute (NESCI). They also worked with spin-out company Reinnervate; local SME, High Force Research Ltd and Newcastle University.
Dr Przyborski said: “The key thing about these synthetic molecules is that they remain stable and are exactly the same every time you use them, ensuring more reliable scientific experiments compared to those which use ATRA. Because the results will be more scientifically robust, this will accelerate drug development using human stem cell-derived tissues and potentially reduce the numbers of animals used in such research”
“Another significant characteristic of these synthetic molecules is that they direct stem cells down specific pathways, meaning that they, individually, will be useful for very specific types of drug development work. EC23, for example, produces almost 40 per cent more neurons than ATRA.”
Dr Whiting said: "We've set out to make stable mimics of natural compounds which control cell development, but in this case, not only have we uncovered a compound which is not only stable and does what the natural system does, but it actually seems to be better as well. It’s a real bonus and shows the validity of the approach."
Dr Przyborski, who is also Director and Chief Scientific Officer of spin-out company Reinnervate Limited, is currently marketing EC23 through Reinnervate. He said the results showed that synthetic retinoids EC23 and EC19 could be used to replace All-trans-retinoic acid (ATRA).
ATRA is sensitive to light, heat and air, and exposure to light especially causes it to degrade rapidly, meaning scientists are never sure exactly what concentration or what mixture of isomers they are working with. The experiments on EC23 and EC19, which included highly detailed analysis by Nuclear Magnetic Resonance (NMR) showed that these synthetic molecules were not sensitive to light and therefore did not degrade.
The scientists are now developing a ‘molecular toolkit’ of synthetic compounds which are tailor made for specific stem cell and drug development work. The project was funded in part by Reinnervate, the regional development agency, One NorthEast, Durham University, High Force Research Ltd., NESCI, and by research councils the MRC, EPSRC, BBSRC.
Original Article; Christie V et al Org.Biomeol.Chem, 2008, DOI:10.1039/b808574a
Switch Discovered to Convert Blood Vessels to Blood Stem Cells During Embryonic DevelopmentNews
Findings could aid research into creating new blood cells for transplants and understanding cancer metastasis.READ MORE
Unraveling How Mesenchymal Stem Cells From Gum Tissue Accelerate Wound HealingNews
To assist with wound healing, mesenchymal stem cells from the gum tissue secrete extracellular vesicles that contain the anti-inflammatory signaling molecule IL-1RA.READ MORE